For the year ending 2025-12-31, TCRX has $228,789K in assets. $105,666K in debts. $152,406K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 152,406 | |||
| Prepaid expenses and other current assets | 4,802 | |||
| Total current assets | 157,208 | |||
| Property and equipment | 30,276 | |||
| Less accumulated depreciation and amortization | 21,570 | |||
| Property and equipment, net | 8,706 | |||
| Right-of-use assets | 57,743 | |||
| Restricted cash | 5,031 | |||
| Long-term deposit and other assets | 101 | |||
| Total assets | 228,789 | |||
| Accounts payable | 1,241 | |||
| Accrued expenses and other current liabilities | 7,668 | |||
| Operating lease liability, current portion | 7,167 | |||
| Deferred revenue, current portion | 2,619 | |||
| Total current liabilities | 18,695 | |||
| Operating lease liability, net of current portion | 54,437 | |||
| Long-term debt and accrued interest | 32,534 | |||
| Total liabilities | 105,666 | |||
| Common stock-Voting Common Stock | 5 | |||
| Common stock-Nonvoting Common Stock | 1 | |||
| Additional paid-in capital | 627,979 | |||
| Accumulated deficit | -504,862 | |||
| Total stockholders' equity | 123,123 | |||
| Total liabilities and stockholders' equity | 228,789 | |||
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)